[Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB). 2nd Update 2016]

Semlitsch T, Horvath K
Record ID 32016000991
German
Authors' objectives: This systematic review is the second update of the systematic review "drug-eluting balloon (DEB)" compiled in 2009, and first updated in 2013. The aim of this systematic review was to assess the efficacy and safety of percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB) compared to PTCA with uncoated balloon (UCB) or implantation of a drug-eluting stent (DES) for the treatment of instent restenosis (ISR), small coronary vessel disease (SVD), ostium stenosis and de-novo lesions of coronary vessels.
Authors' recommendations: Current evidence suggests a benefit for PTCA with DEB vs. PTCA with UCB in ISR, but no difference in efficacy and safety of PTCA with DEB and DES implantation – the first line therapy recommended in current guidelines – in ISR or de-novo lesions. For SVD the current evidence is insufficient to assess the efficacy and safety of PTCA with DEB in comparison to DES implantation. We recommend a re-evaluation for SVD in 2020. For ISR, de-novo lesions and ostium stenosis a re-evaluation is not recommended. Based on the current evidence, the inclusion of PTCA with DEB into the Austrian hospital benefit catalogue is not recommended.
Details
Project Status: Completed
URL for project: http://eprints.hta.lbg.ac.at/1093/
Year Published: 2016
URL for published report: http://eprints.hta.lbg.ac.at/1093/1/DSD_24_Update2016.pdf
URL for additional information: http://hta.lbg.ac.at/page/bewertung-medizinischer-einzelleistungen-mel-berichte/en
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Austria
MeSH Terms
  • Angioplasty, Balloon, Coronary
  • Coronary Angiography
  • Coronary Vessels
  • Humans
Contact
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
Copyright: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.